MAVS anticorps
-
- Antigène Voir toutes MAVS Anticorps
- MAVS (Mitochondrial Antiviral Signaling Protein (MAVS))
-
Reactivité
- Humain, Souris
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp MAVS est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Purification
- Affinity purification
- Immunogène
- Synthetic peptide of human MAVS
- Isotype
- IgG
- Top Product
- Discover our top product MAVS Anticorps primaire
-
-
- Indications d'application
- WB 1:500-1:2000, IHC 1:50-1:200
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.6 mg/mL
- Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
- Agent conservateur
- Sodium azide
- Conseil sur la manipulation
- Avoid freeze / thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Antigène
- MAVS (Mitochondrial Antiviral Signaling Protein (MAVS))
- Autre désignation
- MAVS (MAVS Produits)
- Synonymes
- anticorps CARDIF, anticorps IPS-1, anticorps IPS1, anticorps VISA, anticorps D430028G21Rik, anticorps Visa, anticorps cardif, anticorps wu:fj20d04, anticorps zgc:158392, anticorps mitochondrial antiviral signaling protein, anticorps MAVS, anticorps Mavs, anticorps mavs
- Sujet
- This gene encodes an intermediary protein necessary in the virus-triggered beta interferon signaling pathways. It is required for activation of transcription factors which regulate expression of beta interferon and contributes to antiviral immunity. Multiple transcript variants encoding different isoforms have been found for this gene
- Poids moléculaire
- Calculated MW: 57 kDa
- NCBI Accession
- NP_065797
- Pathways
- Activation of Innate immune Response, Inositol Metabolic Process, Hepatitis C
-